Condition: Healthy Volunteers, Pulmonary Arterial Hypertension · Sponsor: Novartis Pharmaceuticals
A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
This description comes directly from the study's public registry record.
Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com
Novartis Pharmaceuticals · +41613241111
Always discuss trial participation with your own doctor first.
| Arizona Pulmonary Specialists Ltd | Scottsdale, Arizona, United States | Recruiting |
| UC Irvine Medical Center | Orange, California, United States | Recruiting |
| Stanford Medical Center | Stanford, California, United States | Recruiting |
| Univ Colorado Hospital | Aurora, Colorado, United States | Recruiting |
| Central Florida Pulmonary Group | Orlando, Florida, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Emory University School of Medicine | Atlanta, Georgia, United States | Recruiting |
| U of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
| Norton Infectious Diseases Specialists | Louisville, Kentucky, United States | Recruiting |
| Tufts Medical Center | Boston, Massachusetts, United States | Recruiting |
| Lahey Hospital and Medical Center | Burlington, Massachusetts, United States | Recruiting |
| Sky Integrative Medical Center SKYCRNG PPDS | Ridgeland, Mississippi, United States | Recruiting |
+ 75 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06649110